Pluri Inc. Other Comprehensive Income (Loss), before Reclassifications, Net of Tax
Pluri Inc. (PLUR) reported Other Comprehensive Income (Loss), before Reclassifications, Net of Tax of -$1.07 million for the 12-month period ending 2016-06-30, per its 10-K filed 2016-09-07.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax · last filed 2016-09-07
- Pluri Inc. other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2016-06-30 was $395.00K, a 56.97% decline year-over-year.
- Pluri Inc. other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2016-03-31 was -$120.00K, a 105.56% decline year-over-year.
- Pluri Inc. other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2015-12-31 was $464.00K, a 350.49% increase year-over-year.
- Pluri Inc. other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2015-09-30 was -$1.81M.
- Pluri Inc. other comprehensive income (loss), before reclassifications, net of tax for fiscal 2016 was -$1.07M.
- Pluri Inc. other comprehensive income (loss), before reclassifications, net of tax for fiscal 2015 was -$1.11M, a 132.36% decline from fiscal 2014.
- Pluri Inc. other comprehensive income (loss), before reclassifications, net of tax for fiscal 2014 was $3.43M.
| Period end | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 3 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 6 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 9 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 12 month |
|---|---|---|---|---|
| 2016-06-30 | $395.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-07 | $275.00K derived: sum of 2 quarters · filed 2016-09-07 | $739.00K derived: sum of 3 quarters · filed 2016-09-07 | -$1.07M 10-K · filed 2016-09-07 |
| 2016-03-31 | -$120.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-09 | $344.00K derived: sum of 2 quarters · filed 2016-05-09 | -$1.47M 10-Q · filed 2016-05-09 | -$548.00K derived: sum of 4 quarters · filed 2016-05-09 |
| 2015-12-31 | $464.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-08 | -$1.35M 10-Q · filed 2016-02-08 | -$428.00K derived: sum of 3 quarters · filed 2016-02-08 | $1.73M derived: sum of 4 quarters · filed 2016-02-08 |
| 2015-09-30 | -$1.81M 10-Q · filed 2015-11-05 | -$892.00K derived: sum of 2 quarters · filed 2015-11-05 | $1.27M derived: sum of 3 quarters · filed 2015-11-05 | $1.37M derived: sum of 4 quarters · filed 2015-11-05 |
| 2015-06-30 | $918.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-09 | $3.08M derived: sum of 2 quarters · filed 2015-09-09 | $3.18M derived: sum of 3 quarters · filed 2015-09-09 | -$1.11M 10-K · filed 2015-09-09 |
| 2015-03-31 | $2.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-06 | $2.26M derived: sum of 2 quarters · filed 2015-05-06 | -$2.03M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $103.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-05 | -$4.18M 10-Q · filed 2015-02-05 | ||
| 2014-09-30 | -$4.29M 10-Q · filed 2014-11-06 | |||
| 2014-06-30 | $3.43M 10-K · filed 2014-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |